ESC 365 - Prognostic value of reticulocyte production ability in patients with chronic heart failure

ESC Professional Premium Access

Prognostic value of reticulocyte production ability in patients with chronic heart failure

Session: Models to predict unfavourable outcomes in heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor M. Nakao (Sapporo, JP)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Motoki Nakao

Hokkaido University, Sapporo (Japan)

0 follower

8 more presentations in this session

Risk prediction models for incident heart failure: a systematic review and meta-analysis

Speaker: Mr J. Navarro (Toronto, CA)

A flexible, calibrated transformer-based risk model for prediction of clinical outcomes in patients with heart failure; an open cohort study using linked UK EHR

Speaker: Doctor S. Rao (Oxford, GB)

Explainable machine learning and multi-modal data for predicting readmission in patients with heart failure

Speaker: Ms R. Chae (US)

Prognostic implications of genotype findings in non-ischemic dilated cardiomyopathy: a network meta-analysis

Speaker: Doctor V. Anastasiou (Thessaloniki, GR)

Development and validation of a predicting model for risk of mortality in heart failure patients with mildly reduced ejection fraction post discharge

Speaker: Professor Y. Zhu (Xiangtan, CN)

Access the full session

Models to predict unfavourable outcomes in heart failure

Speakers: Doctor M. Nakao, Mr J. Navarro, Doctor S. Rao, Ms R. Chae, Doctor V. Anastasiou...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources